10x Genomics

Single-cell precision diagnostics

Pleasanton, California, US

An American biotechnology company that designs and manufactures sequencing technologies focused on single-cell and spatial omics for scientific research, providing integrated solutions including instruments, consumables, and software.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out 10x Genomics on @MedStartr Today An American biotechnology company that designs and manufactures sequencing technologies focused on single-cell and spatial omics for scientific research, providing integrated solutions including instruments, consumables, and software. https://www.linkedin.com/company/10xgenomics #Cardiology #Immunology #Neuroscience #CancerResearch #InfectiousDiseases #CancerOncology #PrecisionMedicineDiagnostics #MedMo #MedStartrVentures

https://www.medstartr.ai/s/l5dFFAhStnE

Get Involved in 10x Genomics

How We Help

Problem Statement

Researchers need advanced technologies to analyze complex biological systems at a single-cell and spatial level to gain deeper insights into disease mechanisms and accelerate drug development.

Core Technology

microfluidics-based method of single-cell RNA sequencing, Chromium system, Next GEM technology, Chromium platform for single-cell sequencing applications (scRNA-seq, scATAC-seq, scMultiome)

Key Differentiators

Focus on single-cell and spatial omics for scientific research; Microfluidics-based method of single-cell RNA sequencing; Integrated solutions including instruments, consumables, and software; Chromium system and Next GEM technology; Chromium platform supports various single-cell sequencing applications (scRNA-seq, scATAC-seq, scMultiome)

Clinical Focus

Diagnostics

Company Info

Business Model: Hybrid
Founded: 2012
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: 10xgenomics.com

Disease Areas

Cardiology Immunology Neuroscience Cancer Research Infectious Diseases Cancer & Oncology

Technologies

Single-Cell SequencingSpatial OmicsMicrofluidicsscRNA-seqscATAC-seqscMultiomeSingle Cell GenomicsSpatial GenomicsMultiomicsBioinformaticsGene SequencingSpatial TranscriptomicsGenomicsLife Science ToolsBiotechnologyLife Sciences

Clinical & IP

🔬

Clinical Validation

Announced 2026 clinical entry at JPMorgan with three major academic partnerships. CLIA lab launch planned. Active biomarker research correlating single-cell data to clinical outcomes.

🌐Website 💼LinkedIn

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of 10x Genomics?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.